MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jbmr/zjae090

Медицинская библиотека · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024

Osteoporosis treatment prevents hip fracture similarly in both sexes: the FOCUS observational study.

Keaveny Tony M, Adams Annette L, Orwoll Eric S, Khosla Sundeep, Siris Ethel S, McClung Michael R, Bouxsein Mary L, Fatemi Shireen, Lee David C, Kopperdahl David L

СтатьяНаблюдательное исследованиеПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

Randomized trials have not been performed, and may never be, to determine if osteoporosis treatment prevents hip fracture in men. Addressing that evidence gap, we analyzed data from an observational study of new hip fractures in a large integrated healthcare system to compare the reduction in hip fractures associated with standard-of-care osteoporosis treatment in men versus women. Sampling from 271,389 patients aged ≥ 65 who had a hip-containing CT scan during care between 2005 and 2018, we selected all who subsequently had a first hip fracture (cases) after the CT scan (start of observation) and a sex-matched equal number of randomly selected patients. From those, we analyzed all who tested positive for osteoporosis (DXA-equivalent hip BMD T-score ≤ -2.5, measured from the CT scan using VirtuOst). We defined "treated" as at least six months of any osteoporosis medication by prescription fill data during follow-up; "not-treated" was no prescription fill. Sex-specific odds ratios of hip fracture for treated vs not-treated patients were calculated by logistic regression; adjustments included age, BMD T-score, BMD-treatment interaction, BMD, race/ethnicity, and seven baseline clinical risk factors. At two-year follow-up, 33.9% of the women (750/2,211 patients) and 24.0% of the men (175/728 patients) were treated primarily with alendronate; 51.3% and 66.3%, respectively, were not-treated; and 721 and 269, respectively, had a first hip fracture since the CT scan. Odds ratio of hip fracture for treated vs not-treated was 0.26 (95% confidence interval: 0.21-0.33) for women and 0.21 (0.13-0.34) for men; the ratio of these odds ratios (men:women) was 0.81 (0.47-1.37), indicating no significant sex effect. Various sensitivity and stratified analyses confirmed these trends, including results at five-year follow-up. Given these results and considering the relevant literature, we conclude that osteoporosis treatment prevents hip fracture similarly in both sexes.

Для цитирования: Keaveny Tony M, Adams Annette L, Orwoll Eric S, Khosla Sundeep, Siris Ethel S, McClung Michael R, Bouxsein Mary L, Fatemi Shireen, Lee David C, Kopperdahl David L. Osteoporosis treatment prevents hip fracture similarly in both sexes: the FOCUS observational study.. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2024. DOI: 10.1093/jbmr/zjae090.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.